![]() Extra Corporeal Membrane Oxygenation (ECMO) System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Modality (Veno-Arterial (VA), Veno-Venous (VV), Others), By Application (Respiratory Applications, Cardiac Applications, Extracorporeal Cardiopulmonary Resuscitation (ECPR)), By End-User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region and Competition, 2020-2030F
Global Extra Corporeal Membrane Oxygenation (ECMO) System Market was valued at USD 571.20 Million in 2024 and is expected to reach USD 782.48 Million in the forecast period with a CAGR of 5.36% thr... もっと見る
SummaryGlobal Extra Corporeal Membrane Oxygenation (ECMO) System Market was valued at USD 571.20 Million in 2024 and is expected to reach USD 782.48 Million in the forecast period with a CAGR of 5.36% through 2030. The Extracorporeal Membrane Oxygenation (ECMO) System Market is experiencing significant expansion due to the growing demand for advanced life-support technologies in critical care settings. ECMO systems play a crucial role in managing patients with severe cardiac and respiratory failure by providing prolonged extracorporeal circulation and oxygenation. Increased awareness among healthcare professionals regarding the effectiveness of ECMO in improving survival rates has contributed to its widespread adoption. The integration of innovative features such as real-time monitoring, compact designs, and automation is further enhancing system performance and usability. Rising cases of cardiovascular diseases, respiratory disorders, and organ failure are driving the need for ECMO, particularly in intensive care units (ICUs) and specialized cardiac centers. Advancements in medical technologies are also improving patient outcomes, making ECMO a preferred intervention in life-threatening conditions.Advancements in ECMO technology are reshaping the market, leading to the development of portable and user-friendly systems. Increasing investments in research and development have resulted in devices with enhanced efficiency, reduced complications, and improved patient safety. The growing preference for minimally invasive and percutaneous ECMO cannulation techniques has reduced procedural risks and expanded the applicability of ECMO beyond traditional hospital settings. An increasing number of heart and lung transplant procedures also necessitate the use of ECMO for perioperative support, further driving market growth. The integration of artificial intelligence (AI) and data analytics is helping clinicians monitor and optimize ECMO performance, leading to better patient management. Favorable reimbursement policies in developed countries are enhancing patient access to ECMO therapy, while the growing focus on neonatal and pediatric care is expanding the target patient population. Collaborations between healthcare providers and medical device manufacturers are accelerating the adoption of ECMO systems, particularly in emerging markets where critical care infrastructure is rapidly developing. Key Market Drivers Advancements in Medical Technology Advancements in medical technology have significantly enhanced extracorporeal membrane oxygenation (ECMO) systems, improving their efficacy, safety, and overall utility. These innovations are particularly crucial given the rising prevalence of cardiovascular diseases (CVDs) and respiratory failures, which are leading causes of mortality globally. In the United States, heart disease remains the leading cause of death, accounting for 702,880 fatalities in 2022, which represents 1 in every 5 deaths. Coronary heart disease (CHD) is the most common type, responsible for 371,506 deaths in the same year. Additionally, about 1 in 20 adults aged 20 and older have CHD. Each year, approximately 805,000 Americans experience a heart attack, with 605,000 being first occurrences and 200,000 happening in individuals who have already had a heart attack. Key Market Challenges High Costs and Resource Intensity ECMO therapy is a highly specialized and resource-intensive medical intervention. The equipment itself is expensive, and the overall cost of ECMO treatment includes not only the machine but also the required disposables, personnel, and infrastructure. Running an ECMO program demands a skilled team of healthcare professionals, including perfusionists and specially trained nurses, as well as dedicated facilities with the necessary technology and expertise. Financial Burden: The high upfront costs associated with establishing and maintaining an ECMO program can be a substantial financial burden for healthcare institutions, particularly smaller hospitals and clinics. Due to the resource-intensive nature of ECMO, it may not be readily available in all healthcare settings, limiting access for patients in remote areas or regions with fewer healthcare resources. The cost barrier can exacerbate healthcare disparities, as not all patients may have equal access to ECMO treatment, potentially leading to unequal outcomes based on socioeconomic factors. Key Market Trends Technological Advancements and Miniaturization One prominent trend in the global ECMO System Market is the continuous advancement of technology and the development of more compact, portable ECMO systems. This trend aims to make ECMO therapy more accessible and versatile. Miniaturized ECMO Machines: Manufacturers are working on creating smaller, more portable ECMO machines that are easier to transport and set up. This makes ECMO treatment feasible in a wider range of healthcare settings, including ambulances and remote clinics. ECMO systems are increasingly being integrated with advanced monitoring devices and artificial intelligence algorithms. This integration allows for real-time monitoring of patient vitals, helping healthcare providers make informed decisions and detect complications earlier. Some ECMO systems now offer wireless connectivity, enabling healthcare teams to monitor patients remotely. This feature is especially valuable for critical care patients who require continuous monitoring even during inter-hospital transfers. Key Market Players • LivaNova (Alung Technologies Inc.) • Eurosets • Getinge AB • Medtronic PLC • Microport Scientific Corporation • Nipro Medical Corporation • Terumo Medical Corporation • Abbott Laboratories • Fresenius Medical Care Company Report Scope: In this report, the Global Extra Corporeal Membrane Oxygenation (ECMO) System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below: • Extra Corporeal Membrane Oxygenation (ECMO) System Market, By Modality: o Veno-Arterial (VA) o Veno-Venous (VV) o Others • Extra Corporeal Membrane Oxygenation (ECMO) System Market, By Application: o Respiratory Applications o Cardiac Applications o Extracorporeal Cardiopulmonary Resuscitation (ECPR) • Extra Corporeal Membrane Oxygenation (ECMO) System Market, By End-User: o Hospitals & Clinics o Ambulatory Care Centers o Others • Extra Corporeal Membrane Oxygenation (ECMO) System Market, By Region: o North America § United States § Canada § Mexico o Europe § France § United Kingdom § Italy § Germany § Spain o Asia-Pacific § China § India § Japan § Australia § South Korea o South America § Brazil § Argentina § Colombia o Middle East & Africa § South Africa § Saudi Arabia § UAE Competitive Landscape Company Profiles: Detailed analysis of the major companies present in the Global Extra Corporeal Membrane Oxygenation (ECMO) System Market. Available Customizations: Global Extra Corporeal Membrane Oxygenation (ECMO) System market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: Company Information • Detailed analysis and profiling of additional market players (up to five). Table of Contents1. Product Overview1.1. Market Definition 1.2. Scope of the Market 1.2.1. Markets Covered 1.2.2. Years Considered for Study 1.2.3. Key Market Segmentations 2. Research Methodology 2.1. Objective of the Study 2.2. Baseline Methodology 2.3. Key Industry Partners 2.4. Major Association and Secondary Sources 2.5. Forecasting Methodology 2.6. Data Triangulation & Validation 2.7. Assumptions and Limitations 3. Executive Summary 3.1. Overview of the Market 3.2. Overview of Key Market Segmentations 3.3. Overview of Key Market Players 3.4. Overview of Key Regions/Countries 3.5. Overview of Market Drivers, Challenges, Trends 4. Voice of Customer 5. Global Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook 5.1. Market Size & Forecast 5.1.1. By Value 5.2. Market Share & Forecast 5.2.1. By Modality (Veno-Arterial (VA), Veno-Venous (VV), Others) 5.2.2. By Application (Respiratory Applications, Cardiac Applications, Extracorporeal Cardiopulmonary Resuscitation (ECPR)) 5.2.3. By End-User (Hospitals & Clinics, Ambulatory Care Centers, Others) 5.2.4. By Region 5.2.5. By Company (2024) 5.3. Market Map 6. North America Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook 6.1. Market Size & Forecast 6.1.1. By Value 6.2. Market Share & Forecast 6.2.1. By Modality 6.2.2. By Application 6.2.3. By End-User 6.2.4. By Country 6.3. North America: Country Analysis 6.3.1. United States Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook 6.3.1.1. Market Size & Forecast 6.3.1.1.1. By Value 6.3.1.2. Market Share & Forecast 6.3.1.2.1. By Modality 6.3.1.2.2. By Application 6.3.1.2.3. By End-User 6.3.2. Canada Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook 6.3.2.1. Market Size & Forecast 6.3.2.1.1. By Value 6.3.2.2. Market Share & Forecast 6.3.2.2.1. By Modality 6.3.2.2.2. By Application 6.3.2.2.3. By End-User 6.3.3. Mexico Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook 6.3.3.1. Market Size & Forecast 6.3.3.1.1. By Value 6.3.3.2. Market Share & Forecast 6.3.3.2.1. By Modality 6.3.3.2.2. By Application 6.3.3.2.3. By End-User 7. Europe Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook 7.1. Market Size & Forecast 7.1.1. By Value 7.2. Market Share & Forecast 7.2.1. By Modality 7.2.2. By Application 7.2.3. By End-User 7.3. Europe: Country Analysis 7.3.1. Germany Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook 7.3.1.1. Market Size & Forecast 7.3.1.1.1. By Value 7.3.1.2. Market Share & Forecast 7.3.1.2.1. By Modality 7.3.1.2.2. By Application 7.3.1.2.3. By End-User 7.3.2. United Kingdom Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook 7.3.2.1. Market Size & Forecast 7.3.2.1.1. By Value 7.3.2.2. Market Share & Forecast 7.3.2.2.1. By Modality 7.3.2.2.2. By Application 7.3.2.2.3. By End-User 7.3.3. Italy Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook 7.3.3.1. Market Size & Forecast 7.3.3.1.1. By Value 7.3.3.2. Market Share & Forecasty 7.3.3.2.1. By Modality 7.3.3.2.2. By Application 7.3.3.2.3. By End-User 7.3.4. France Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook 7.3.4.1. Market Size & Forecast 7.3.4.1.1. By Value 7.3.4.2. Market Share & Forecast 7.3.4.2.1. By Modality 7.3.4.2.2. By Application 7.3.4.2.3. By End-User 7.3.5. Spain Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook 7.3.5.1. Market Size & Forecast 7.3.5.1.1. By Value 7.3.5.2. Market Share & Forecast 7.3.5.2.1. By Modality 7.3.5.2.2. By Application 7.3.5.2.3. By End-User 8. Asia-Pacific Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook 8.1. Market Size & Forecast 8.1.1. By Value 8.2. Market Share & Forecast 8.2.1. By Modality 8.2.2. By Application 8.2.3. By End-User 8.3. Asia-Pacific: Country Analysis 8.3.1. China Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook 8.3.1.1. Market Size & Forecast 8.3.1.1.1. By Value 8.3.1.2. Market Share & Forecast 8.3.1.2.1. By Modality 8.3.1.2.2. By Application 8.3.1.2.3. By End-User 8.3.2. India Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook 8.3.2.1. Market Size & Forecast 8.3.2.1.1. By Value 8.3.2.2. Market Share & Forecast 8.3.2.2.1. By Modality 8.3.2.2.2. By Application 8.3.2.2.3. By End-User 8.3.3. Japan Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook 8.3.3.1. Market Size & Forecast 8.3.3.1.1. By Value 8.3.3.2. Market Share & Forecast 8.3.3.2.1. By Modality 8.3.3.2.2. By Application 8.3.3.2.3. By End-User 8.3.4. South Korea Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook 8.3.4.1. Market Size & Forecast 8.3.4.1.1. By Value 8.3.4.2. Market Share & Forecast 8.3.4.2.1. By Modality 8.3.4.2.2. By Application 8.3.4.2.3. By End-User 8.3.5. Australia Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook 8.3.5.1. Market Size & Forecast 8.3.5.1.1. By Value 8.3.5.2. Market Share & Forecast 8.3.5.2.1. By Modality 8.3.5.2.2. By Application 8.3.5.2.3. By End-User 9. South America Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook 9.1. Market Size & Forecast 9.1.1. By Value 9.2. Market Share & Forecast 9.2.1. By Modality 9.2.2. By Application 9.2.3. By End-User 9.3. South America: Country Analysis 9.3.1. Brazil Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook 9.3.1.1. Market Size & Forecast 9.3.1.1.1. By Value 9.3.1.2. Market Share & Forecast 9.3.1.2.1. By Modality 9.3.1.2.2. By Application 9.3.1.2.3. By End-User 9.3.2. Argentina Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook 9.3.2.1. Market Size & Forecast 9.3.2.1.1. By Value 9.3.2.2. Market Share & Forecast 9.3.2.2.1. By Modality 9.3.2.2.2. By Application 9.3.2.2.3. By End-User 9.3.3. Colombia Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook 9.3.3.1. Market Size & Forecast 9.3.3.1.1. By Value 9.3.3.2. Market Share & Forecast 9.3.3.2.1. By Modality 9.3.3.2.2. By Application 9.3.3.2.3. By End-User 10. Middle East and Africa Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook 10.1. Market Size & Forecast 10.1.1. By Value 10.2. Market Share & Forecast 10.2.1. By Modality 10.2.2. By Application 10.2.3. By End-User 10.3. MEA: Country Analysis 10.3.1. South Africa Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook 10.3.1.1. Market Size & Forecast 10.3.1.1.1. By Value 10.3.1.2. Market Share & Forecast 10.3.1.2.1. By Modality 10.3.1.2.2. By Application 10.3.1.2.3. By End-User 10.3.2. Saudi Arabia Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook 10.3.2.1. Market Size & Forecast 10.3.2.1.1. By Value 10.3.2.2. Market Share & Forecast 10.3.2.2.1. By Modality 10.3.2.2.2. By Application 10.3.2.2.3. By End-User 10.3.3. UAE Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook 10.3.3.1. Market Size & Forecast 10.3.3.1.1. By Value 10.3.3.2. Market Share & Forecast 10.3.3.2.1. By Modality 10.3.3.2.2. By Application 10.3.3.2.3. By End-User 11. Market Dynamics 11.1. Drivers & Challenges 12. Market Trends & Developments 12.1. Recent Developments 12.2. Product Launches 12.3. Mergers & Acquisitions 13. Global Extra Corporeal Membrane Oxygenation (ECMO) System Market: SWOT Analysis 14. Competitive Landscape 14.5.1. LivaNova (Alung Technologies Inc.) 14.5.2. Eurosets 14.5.3. Getinge AB 14.5.4. Medtronic PLC 14.5.5. Microport Scientific Corporation 14.5.6. Nipro Medical Corporation 14.5.7. Terumo Medical Corporation 14.5.8. Abbott Laboratories 14.5.9. Fresenius Medical Care Company 15. Strategic Recommendations 16. About Us & Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
TechSci Research社のヘルスケア分野での最新刊レポート
本レポートと同じKEY WORD(membrane)の最新刊レポート
よくあるご質問TechSci Research社はどのような調査会社ですか?テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|